Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Theranostics
|
July 10, 2020
A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis
Yixin Chen, Yanying Zhou, Fangwei Han, et al.
Oncotarget
|
April 19, 2017
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models
Chao Jian, Mei-Juan Tu, Pui Yan Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2018
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Pui Yan Ho, Zhijian Duan, Neelu Batra, et al.
Cancers
|
February 25, 2022
The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies
Anastasia L Berg, Ashley Rowson-Hodel, Michelle Hu, et al.
Clinical Pharmacology and Therapeutics
|
August 24, 2022
DNA-Thioguanine Nucleotides as a Marker for Thiopurine Induced Late Leukopenia after Dose Optimizing by NUDT15 C415T in Chinese Patients with IBD
Xia Zhu, Kang Chao, Ting Yang, et al.
Cancer Chemotherapy and Pharmacology
|
July 30, 2022
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer
Justin A Chen, Jasmine C Huynh, Chun-Yi Wu, et al.
Nature Communications
|
January 4, 2024
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy
Zhangyi Luo, Yixian Huang, Neelu Batra, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 30, 2015
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization
Wei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, et al.
Acta Pharmaceutica Sinica. B
|
April 8, 2017
Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21<sup>st</sup> International Symposium on Microsomes and Drug Oxidations (MDO)
Ai-Ming Yu, Magnus Ingelman-Sundberg, Nathan J Cherrington, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Theranostics
|
July 10, 2020
A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis
Yixin Chen, Yanying Zhou, Fangwei Han, et al.
Oncotarget
|
April 19, 2017
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse models
Chao Jian, Mei-Juan Tu, Pui Yan Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 2018
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Pui Yan Ho, Zhijian Duan, Neelu Batra, et al.
Cancers
|
February 25, 2022
The Cationic Amphiphilic Drug Hexamethylene Amiloride Eradicates Bulk Breast Cancer Cells and Therapy-Resistant Subpopulations with Similar Efficiencies
Anastasia L Berg, Ashley Rowson-Hodel, Michelle Hu, et al.
Clinical Pharmacology and Therapeutics
|
August 24, 2022
DNA-Thioguanine Nucleotides as a Marker for Thiopurine Induced Late Leukopenia after Dose Optimizing by NUDT15 C415T in Chinese Patients with IBD
Xia Zhu, Kang Chao, Ting Yang, et al.
Cancer Chemotherapy and Pharmacology
|
July 30, 2022
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer
Justin A Chen, Jasmine C Huynh, Chun-Yi Wu, et al.
Nature Communications
|
January 4, 2024
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy
Zhangyi Luo, Yixian Huang, Neelu Batra, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 30, 2015
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization
Wei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, et al.
Acta Pharmaceutica Sinica. B
|
April 8, 2017
Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21<sup>st</sup> International Symposium on Microsomes and Drug Oxidations (MDO)
Ai-Ming Yu, Magnus Ingelman-Sundberg, Nathan J Cherrington, et al.
Page
of 14